Banks and telcos lead big data analytics spending in APAC
Banks and telcos contributed nearly one-third of spending on big data analytics in the region, while the government and healthcare sectors will register the highest growth rates, new research finds
Share this item with your network: By Published: 15 Jan 2021 4:26
At the height of the Covid-19 pandemic, Indonesia’s Bank Mandiri used its big data platform to determine which branches should remain operational and gave that information to customers and the government’s financial services authority.
In Australia, the Murdoch Children’s Research Institute in Melbourne is working on a big data project to bring together multiple data sources so that doctors can intervene earlier in childhood conditions.
By Anthony King, additional reporting by Bojan Stojkovski2021-01-14T16:35:00+00:00
As 2020 ended, news of the first Covid-19 vaccine approvals came as a huge relief to national governments and their citizens. Yet with Covid-19 infection rates rising in many countries, and with more infectious variants of the virus emerging, the need for widespread vaccination grows more urgent and regulators around the world are now racing to assess and approve vaccines.
The BioNTech-Pfizer vaccine was first approved by the UK on 2 December and now has approval in almost 50 countries. Moderna’s vaccine also gained emergency approval in the US and the UK in December, with the European Medicines Agency (EMA) greenlighting it last week. Both are RNA vaccines and have shown efficacies of around 95% in their clinical trials.
The Federal Government's working on a 24 million dollar COVID vaccine public health campaign to encourage Australians to come forward to get their shot.
BCG vaccine trial extends across Devon, in partnership with RD&E
A large global trial designed to test the theory that the widely used BCG vaccine might help protect against COVID-19 amongst healthcare staff and care home workers in the UK continues to recruit participants.
The Exeter study site started recruitment in October and is ongoing in the UK and globally. Now, the University of Exeter has partnered with the Royal Devon & Exeter NHS Trust (RD&E) to recruit staff, and has opened new clinics in Teignmouth and North Devon
Researchers in the trial said that as well as finding out if the BCG vaccine reduced COVID-19 disease severity, they would also be testing whether it could boost the effect of specific COVID-19 vaccines by training the body’s immune system.
GP Sam Hilton signs up to BRACE
A large global trial designed to test the theory that the widely used BCG vaccine might help protect against COVID-19 amongst healthcare staff and care home workers in the UK continues to recruit participants.
The Exeter study site started recruitment in October and is ongoing in the UK and globally. Now, the University of Exeter has partnered with the Royal Devon & Exeter NHS Trust (RD&E) to recruit staff, and has opened new clinics in Teignmouth and North Devon
Researchers in the trial said that as well as finding out if the BCG vaccine reduced COVID-19 disease severity, they would also be testing whether it could boost the effect of specific COVID-19 vaccines by training the body’s immune system.